Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: An international multicenter study

Journal of Clinical Oncology

Volumn 22, Issue 16, 2004, Pages 3316-3322

  Patard, Jean Jacques ^a   Kim, Hyung L ^a   Lam, John S ^a   Dorey, Frederick J ^a   Pantuck, Allan J ^a   Zisman, Amnon ^a   Ficarra, Vincenzo ^a   Han, Ken Ryu ^a   Cindolo, Luca ^a   De La Taille, Alexandre ^a   Tostain, Jacques ^a   Artibani, Walter ^a   Dinney, Colin P ^a   Wood, Christopher G ^a   Swanson, David A ^a   Abbou, Claude C ^a   Lobel, Bernard ^a   Mulders, Peter F A ^a   Chopin, Dominique K ^a   Figlin, Robert A ^a   Belldegrun, Arie S ^a   more..

^a RENNES UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL HETEROGENEITY; CLINICAL TRIAL; DATA BASE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; METASTASIS; MULTICENTER STUDY; PRIORITY JOURNAL; SURVIVAL RATE; TIME SERIES ANALYSIS; UNITED STATES; ADULT; AGED; CANCER STAGING; CLASSIFICATION; EVALUATION; FEMALE; KIDNEY TUMOR; MALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RISK FACTOR; SURVIVAL;

ADULT; AGED; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 4344578504     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.09.104     Document Type: Article

References (18)

1. Pantuck AJ, Zisman A, Belldegrun A: The changing natural history of renal cell carcinoma. J Urol 166:1611-1623, 2001
2. Folkman J: Role of angiogenesis in tumor growth and metastasis. Semin Oncol 29:15-18, 2002
3. Guinan P, Sobin LH, Algaba F, et al: TNM staging of renal cell carcinoma: Workgroup No. 3 - Union International Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 80:992-993, 1997
4. Fuhrman SA, Lasky LC, Limas C: Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6:655-663, 1982
5. Kattan MW, Reuter V, Motzer RJ, et al: A postoperative prognostic nomogram for renal cell carcinoma. J Urol 166:63-67, 2001
6. Frank I, Blute ML, Cheville JC, et al: An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: The SSIGN score. J Urol 168:2395-2400, 2002
7. Zisman A, Pantuck AJ, Dorey F, et al: Improved prognostication of renal cell carcinoma using an integrated staging system. J Clin Oncol 19:1649-1657, 2001
8. Zisman A, Pantuck AJ, Wieder J, et al: Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. J Clin Oncol 20:4559-4566, 2002
9. Kovacs G, Akhtar M, Beckwith BJ, et al: The Heidelberg classification of renal cell tumours. J Pathol 183:131-133, 1997
10. Oken MM, Creech RH, Tormey DC, et al: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649-655, 1982
11. Harrell FE Jr, Lee KL, Mark DB: Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15:361-387, 1996
12. Elson PJ, Witte RS, Trump DL: Prognostic factors for survival in patients with recurrent or metastatic renal cell carcinoma. Cancer Res 48: 7310-7313, 1988
13. Motzer RJ, Mazumdar M, Bacik J, et al: Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. J Clin Oncol 17:2530-2540, 1999
14. Motzer RJ, Bacik J, Murphy BA, et al: Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma. J Clin Oncol 20:289-296, 2002
15. Abou-Jawde RM, Mekhail T, Bou Merhi GF: Prognostic factors (PF) for survival in previously untreated metastatic renal cell cancer (RCC): A comprehensive evaluation and validation of established risk groups. Proc Am Soc Clin Oncol 22:385, 2003(abstr 1545)
16. Han KR, Bleumer I, Pantuck AJ, et al: Validation of an integrated staging system toward improved prognostication of patients with localized renal cell carcinoma in an international population. J Urol 170:2221-2224, 2003
17. Al-Aynati M, Chen V, Salama S, et al: Interobserver and intraobserver variability using the Fuhrman grading system for renal cell carcinoma. Arch Pathol Lab Med 127:593-596, 2003
18. Yang JC, Sherry RM, Steinberg SM, et al: Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancer. J Clin Oncol 21:3127-3132, 2003